rfkjr-kei-13June2025-xtandi June 13, 2025 Robert F. Kennedy, Jr. Secretary U.S. Department of Health and Human Services 200 Independence Ave SW, Washington, DC 20201 RE: Request for issuance of authorization and consent to use federal rights in three patents to supply… Continue Reading
CONFIDENTIAL RELEASED IN FULL CONFIDENTIAL PTQ1906 PAGE 01 GENEVA 03470 01 OF 09 271621Z ACTION 10-00 425261 271705Z /38 O 271615Z MAY 98 FM USMISSION GENEVA TO SECSTATE WASHDC IMMEDIATE 6208 INFO IO COLLECTIVE AMEMBASSY LONDON AMEMBASSY BRASILIA AMEMBASSY BUENOS… Continue Reading
As mentioned in a previous blog, Under the topic of industrial designs, the 48th session of the WIPO Standing Committee on the Law of Trademarks, Industrial Designs and Geographical Indications (SCT) is considering two submissions. The first submission is an… Continue Reading
📅 Date & Time: March 19, 2025 – 1:00-5:00 PM (CET) 📍 Location: WTO, Room S1 (Hybrid Format) 🔗 Zoom Link: https://worldtradeorganization.zoom.us/j/81973510375?pwd=UdaNgKZIdjb8brcbo1GyRVePPn6K6W.1 🆔 Meeting ID: 819 7351 0375 | Passcode: 190305 📌 If you wish to attend online, no previous… Continue Reading
Annually, the Office of the United States Trade Representative spearheads the Special 301 review process, whose goal is to produce a report that names-and-shames countries that have committed perceived offenses against intellectual property rights. The USTR solicits written comments from… Continue Reading
On Wednesday morning, 5 February 2025, Knowledge Ecology International (KEI) delivered the following statement on the rare diseases decision under agenda item 6 on Universal Health Coverage. Item 6 Universal health coverage Knowledge Ecology International A challenge for the rare… Continue Reading
On Monday afternoon, 9 September 2024, Knowledge Ecology International (KEI) delivered this statement on the legal architecture of the proposal for the WHO Pandemic Agreement. KEI has an open mind regarding the appropriate nature of the instrument or instruments for… Continue Reading
On 14 May 2024, the Pharmaceutical Accountability Foundation (PAF) had their first hearing in their case against Abbvie at the Amsterdam District Court. The case concerns Abbvie’s pricing practices for its blockbuster drug Humira (adalimumab), one of the world’s best-selling… Continue Reading
Knowledge Ecology International (KEI) offered the following comments to the National Institutes of Health (NIH) concerning the “Prospective Grant of an Exclusive Patent License: Antibody-Drug Conjugates (ADCs) for Targeting CD56-Positive Tumors” (89 FR 40495) to McSAF Inside Oncology SAS (McSAF).… Continue Reading
National policies and practices as regards the granting of and exceptions to patents, copyrights, and other types of intellectual property are often influenced by pressure from other countries. The United States is the most important source of pressure on intellectual… Continue Reading